Nedira Salzman-Frenkel.
Corporate Officer/Principal bei NEUROSENSE THERAPEUTICS LTD.
Aktive Positionen von Nedira Salzman-Frenkel.
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NEUROSENSE THERAPEUTICS LTD. | Corporate Officer/Principal | 01.03.2022 | - |
Karriereverlauf von Nedira Salzman-Frenkel.
Ehemalige bekannte Positionen von Nedira Salzman-Frenkel.
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Radikal Therapeutics, Inc.
 Radikal Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Radikal Therapeutics, Inc. develops transformative pharmaceuticals of bifunctional edox-based small molecules. The company was founded by Andrew L. Salzman and is headquartered in West Tisbury, MA. | Vorstandsvorsitzender | 01.02.2017 | 01.10.2021 |
Ausbildung von Nedira Salzman-Frenkel.
| Ben-Gurion University of the Negev | Undergraduate Degree |
| The Hebrew University of Jerusalem | Graduate Degree |
| Recanati School of Business Administration | Masters Business Admin |
Statistik
International
| Israel | 5 |
| Vereinigte Staaten | 2 |
Operativ
| Chief Executive Officer | 1 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Consumer Services | 4 |
| Commercial Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NEUROSENSE THERAPEUTICS LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Radikal Therapeutics, Inc.
Radikal Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Radikal Therapeutics, Inc. develops transformative pharmaceuticals of bifunctional edox-based small molecules. The company was founded by Andrew L. Salzman and is headquartered in West Tisbury, MA. | Commercial Services |
- Börse
- Insiders
- Nedira Salzman-Frenkel.
- Erfahrung